-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
- Arcutis Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$52.3M, a 26.3% increase year-over-year.
- Arcutis Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$199M, a 39.9% increase year-over-year.
- Arcutis Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$262M, a 15.8% increase from 2022.
- Arcutis Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$311M, a 50.9% decline from 2021.
- Arcutis Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$206M, a 52.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)